Entera Bio Ltd
NASDAQ:ENTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entera Bio Ltd
NASDAQ:ENTX
|
IL |
|
C
|
CNH Industrial NV
XMUN:37C
|
UK |
|
V
|
Vinacomin HaTu Coal JSC
VN:THT
|
VN |
|
S
|
SHI Corp
OTC:SHCC
|
US |
|
Tekna Holding ASA
F:8VB
|
NO |
|
M
|
Medibank Private Ltd
F:MPV
|
AU |
|
Ekso Bionics Holdings Inc
NASDAQ:CHRN
|
US |
|
C
|
Carpenter Technology Corp
F:XTY
|
US |
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
Intrinsic Value
Is ENTX undervalued or overvalued?
See the intrinsic value estimate for Entera Bio Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ENTX looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ENTX’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Entera Bio Does
Entera Bio is a biotechnology company that tries to turn large drug molecules, especially peptides and proteins, into pills instead of injections. Its core work is developing oral formulations that help these medicines survive the digestive system and reach the bloodstream, which is a hard problem in drug delivery.
- Headquarters
- Israel IL
- Employees
- 20
- IPO date
- Jun 28, 2018
Entera Bio has no economic moat
Entera Bio Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Entera Bio Ltd
Earnings Waterfall
Entera Bio Ltd
The intrinsic value for Entera Bio Ltd (ENTX) under the Base Case is hidden USD.
Compared with the current market price of 2.88 USD, the stock appears hidden.